United States

Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm

NEW YORK, Oct. 18, 2024 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:

Zuora Inc. has agreed to merge with Silver Lake and an affiliate of GIC Pte. Ltd. for $10.00 per share in cash.

ARC Document Solutions, Inc. has agreed to a merger with TechPrint Holdings, LLC, an affiliate of ARC executives, for $3.40 per share.

Kellanova has entered into a definitive agreement with Mars, Incorporated for $83.50 per share in cash.

Revance Therapeutics is set to merge with Crown Laboratories for $6.66 per share in cash.

Why Your Participation Matters:

SHAREHOLDER CASES: ADDRESSING THE INJUSTICE

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at [email protected] or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation – Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Moon K. Young
Chief of Operations
Kuehn Law, PLLC
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker